Our research program is focused on understanding how discrete regions of cell membranes, broadly called “lipid rafts”, influence ocular pathology and physiology. The conceptual framework of lipid rafts places them as organizing nexuses for a variety of cellular signaling events. The goal of our studies is to identify ocular disease-relevant molecular networks localized to lipid rafts that could be modified by raft manipulation. As disease processes are complex, involving significant cross-talk between many signaling pathways, understanding and targeting the nexus, the lipid raft itself, either by disrupting or enhancing its structure/function could be therapeutic.
Education:
- B.A. Human Biology, University of Kansas
- Ph.D. Molecular Biosciences, University of Kansas
- Postdoctoral Fellowship, Department of Ophthalmology, OUHSC
Clinical/Research Interests:
- Caveolae and membrane domains in ocular physiology/pathophysiology
- Neuroprotective and inflammatory signaling in the retina
- Pathophysiology of ocular hypertension/modulation of intraocular pressure
- Ocular vascular aging
Funding:
- Competing NIH R01 renewal EY019494, Role of Caveolin-1 in the Maintenance of Blood-Retinal Barrier Integrity has been renewed for 5 years.
- NIH R01EY028608: Caveolae-based mechanosensors for conventional outflow regulation. Elliott (PI)
- NIH R01EY019494: Role of Caveolin-1 in the Maintenance of Blood-Retinal Barrier Integrity. Elliott (PI)
- Oklahoma Center for Adult Stem Cell Research (OCASCR): Role of Cav1 on Maintenance of Corneal Epithelial Stem Cells- A New Therapy. Elliott (PI)
- Oklahoma Center for the Advancement of Science and Technology (OCAST) HF18-0008: The Role of TRAF3 in Retinal Function and Inflammation (postdoctoral fellowship for Dr. Jami Gurley). Elliott (Sponsor)
- NIH R01EY021238: Corneal Lymphatics & Adaptive Immunity. Carr (PI), Elliott (co-I)
- NIH R01HL132553: Tetraspanin-enriched Microdomains and Endothelial Barrier Function. Zhang (PI), Elliott (co-I)
- NIH P30 EY021725: Core Grant for Vision Research. Anderson (PI), Elliott (Module director)
Select Publications:
- Jozic, I., Abujamra, B. A., Elliott, M. H., Wikramanayake, T. C., Marjanovic, J., Stone, R. C., Head, C. R., Pastar, I., Kirsner, R. S., Andreopoulos, F. M., Musi, J. P., Tomic-Canic, M. (2021). Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds. Commun Biol, 4, 757. PMID: 34145387. DOI: 10.1038/s42003-021-02298-5
- Schafer, C. M., Gurley, J. M., Kurlowicz, K., Lin, P. K., Chen, W., Elliott, M. H., Davis, G. E., Bhatti, F., Griffin, C. T. (2020). An inhibitor of endothelial ETS transcription factors promotes physiologic and therapeutic vessel regression. Proc Natl Acad Sci USA, 117, 26494-26502. PMID: 33020273. DOI: 10.1073/pnas.2015980117
- Gurley, J. M., Gmyrek, G. B., McClellan, M. E., Hargis, E. A., Hauck, S. M., Dozmorov, M. G., Wren, J. D., Carr, D. J., Elliott, M. H. (2020). Neuroretinal-derived caveolin-1 promotes endotoxin-induced inflammation in the murine retina. Invest Ophthalmol Vis Sci, 61, 19. PMID: 33079993. DOI: 10.1167/iovs.61.12.19
- De Ieso, M. L., Gurley, J. M., McClellan, M. E., Gu, X., Navarro, I., Li, G., Gomez-Caraballo, M., Enyong, E., Stamer, W. D., Elliott, M. H. (2020). Physiologic Consequences of Caveolin-1 Ablation in Conventional Outflow Endothelia. Invest Ophthalmol Vis Sci, 61, 32. PMID: 32940661. DOI: 10.1167/iovs.61.11.32
- Li, G., Schmitt, H., Johnson, W. M., Lee, C., Navarro, I., Cui, J., Fleming, T., Gomez-Caraballo, M., Elliott, M. H., Sherwood, J. M., Hauser, M. A., Farsiu, S., Ethier, C. R., Stamer, W. D. (2020). Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior. FASEB J, 34, 10762-10777. PMID: 32623782. DOI: 10.1096/fj.202000702RR